This article summarizes studies of human monocytes/macrophages carried out in my laboratory over a period of more than three decades. Modern studies of mammalian phagocytes began with Metchnikoff in the late 19th century. The early history of this field is summarized in Table 1. In vivo and in vitro studies in animal systems led to the concept of the mononuclear-phagocyte system as a cell system involved in host defenses, phagocytosis, and antigen presentation and processing (11). Following Metchnikoff’s development of phagocyte theory, Wright described opsonins as factors in serum that facilitated phagocytosis. Aschoff defined the reticuloendothelial system as a cellular system in which tissue macrophages and monocytes share important functional characteristics, namely, phagocytic ability and adhesiveness to glass. Subsequently, the histologic development of silver stains by Del Rio-Hortega defined a type of macrophage-related cell in the brain, the microglia. In the mid-1960s, the late Zanvil Cohn and his collaborators carried out seminal studies of mononuclear phagocytes leading to concepts of macrophage differentiation, activation, secretion, and the relationship of macrophages to antigen presentation and processing. My laboratory has had a long-standing commitment to the investigation of human monocytes/macrophages, their normal structure and function, their role in the immunopathogenesis of various disorders, and their functional abnormalities in diseases.
TABLE 1.
Early history of research on mononuclear phagocytes
Yr | Researcher | Area |
---|---|---|
1883 | Elie I. Metchnikoff | Phagocyte theory: microphages (neutrophils), macrophages |
1903 | Almoth E. Wright | Opsonins |
1924 | L. Aschoff | Reticuloendothelial system |
1932 | P. Del Rio-Hortega | Microglia, silver stains |
1965 | Zanvil A. Cohn | Mononuclear-phagocyte differentiation |
(This report was presented as the Abbott Award Lecture in Clinical and Diagnostic Laboratory Immunology at the 97th General Meeting of the American Society for Microbiology, Miami, Fla., May 1997.)
ISOLATION AND PREPARATION OF HUMAN PERIPHERAL BLOOD MONOCYTES AND MACROPHAGES
In our initial studies, we utilized the monocyte isolation method initially developed for horse blood by Bennett and Cohn which we modified for human peripheral blood mononuclear cells, using flotation on high concentrations (28%) of bovine serum albumin (24). The ability to carry out investigations with isolated human monocytes from peripheral blood was greatly facilitated by this development of a method for enrichment and purification of these cells to >98% purity using adherence to microexudate-coated surfaces and subsequent detachment using 5 mM EDTA (1). Subsequently, we further modified this cell isolation method and utilized adherence to gelatin-coated surfaces for a simple and relatively rapid purification of human peripheral blood monocytes (15, 16).
The availability of this technology has made it possible to maintain monocytes in long-term culture (34). Using this cell culture system, we were able to establish and investigate the in vitro differentiation of monocytes into cells which resemble tissue macrophages in structure and immunologic, enzymatic, and functional profiles (34). Furthermore, we demonstrated the constitutive production of lysozyme and inducible production of acid phosphatase by these cells after several days in culture. Following 5 to 7 days in culture, the cells morphologically and biochemically assumed properties of tissue macrophages.
DISORDERS OF MONONUCLEAR PHAGOCYTES
The ability to study mononuclear phagocytes derived from peripheral blood has made it possible to initiate studies of disorders of this important cell system. Disorders of mononuclear phagocytes can be broadly classified into the following eight categories: cell number, proliferation, secretory functions, surface receptors, motility, microbicidal-activity-oxidative, immunoregulatory, and developmental.
MONONUCLEAR PHAGOCYTE RECEPTORS
An array of monocyte/macrophage receptors have now been described (11). These include Fc receptors, complement receptors, cytokine receptors, receptors for peptides and small molecules, hormone receptors, lipoprotein-lipid receptors, receptors for coagulants and anticoagulants, complex saccharide receptors, and others, in particular cholinergic and adrenergic agonist receptors. These receptors have been utilized as markers to study the origin, growth, differentiation, activation, motility, and function of the mononuclear phagocyte. More recently, clinical assays have been developed to detect these receptors on monocytes/macrophages from patients with various disorders.
We were the first to show the immunoglobulin G (IgG) subclass specificity of human monocyte receptor sites, namely, binding of IgG1 and IgG3 (26). We also demonstrated the human monocyte Fc receptor for complement using erythrocytes sensitized with cold autoantibodies (25).
We were the first to demonstrate the dynamic turnover of the human monocyte IgG receptor. In a unique experiment, Schmidt and I added latex particles to adherent monocytes. Following phagocytosis of latex, the IgG Fc receptor was no longer detectable with antibody-coated erythrocytes. This plasma membrane receptor reappeared over a 6- to 8-h period in vitro (32). These experiments were among the first showing the dynamics of plasma membrane receptors in cell biology.
We have also utilized ferritin-labeled antibody to demonstrate at the electron-microscopic level the Fc receptor binding sites on monocytes as delineated by the Rh antibody bound to erythrocytes (5). Using the freeze fracture technique, I demonstrated aggregation of intramembranous particle distribution during interaction of erythrocyte-bound ligands with immunoprotein receptors, in particular Fc and complement receptors (9). These receptors are also readily demonstrable by flow cytometry methods. Using both isotopic and morphological methods, we studied monocyte Fc and complement receptors in clinical disorders.
CLINICAL DISORDERS OF MONOCYTE RECEPTORS
We were able to demonstrate, using quantitative dilutions of Forssman antibody that monocyte Fc receptor activity is enhanced in patients with pulmonary sarcoidosis (6). We further showed increased turnover of Fc receptors, as well as enhanced monocyte Fc receptors in patients with Crohn’s disease and with sarcoidosis (7, 8, 33). We studied monocyte receptors on monocytes derived from patients with immune hemolytic anemias. In these studies, we demonstrated enhanced uptake of autologous coated cells indicating a unique association between the patient’s autoantibody and the monocyte Fc receptor (27).
MICROBICIDAL DISORDERS OF MONOCYTES
Using the albumin flotation technique, we were the first to show a microbicidal defect in circulating monocytes in cells from children with chronic granulomatous disease (4). This study was directly related to the pathophysiology of the disease, namely, the occurrence of lipid-laden macrophages in granulomas and tissue parenchyma. Our studies of monocytes have also included studies on protein calorie malnutrition, a situation in which subtle microbicidal defects occur (10, 14).
MONOCYTES AND HIV INFECTION
We established a system to study monocyte infectivity of human immunodeficiency virus (HIV) using our in vitro culture system (2, 3, 18, 23). We demonstrated that cord blood monocytes/macrophages are more readily infected than monocytes/macrophages derived from adults (22). This important difference may be significant in determining HIV infectibility of the neonate. We have utilized microglia as a system for studying the brain-derived macrophage (17, 23).
NEUROPEPTIDES AND MONOCYTES/MACROPHAGES
We have recently shown that the addition of the neuropeptide substance P (SP) to cultured monocytes/macrophages derived from healthy controls and individuals infected with HIV enhanced HIV expression (19). SP augments interleukin-10 and tumor necrosis factor production by human monocytes and macrophages (20, 30). We have recently demonstrated SP gene expression in human monocytes and macrophages (21). HIV infection of monocytes/macrophages up-regulates the synthesis of SP gene-encoding mRNAs, including the beta, gamma, and delta isoforms of SP (28, 29). This exciting finding is important in understanding the defects of SP and its role on the monocyte/macrophage. Thus, HIV infection of monocytes/macrophages through alteration of SP may be directly relevant to the immunopathogenesis of HIV. We have also developed a chromatographic assay for SP and plasma and demonstrated changes in SP in acute anxiety or stress (patients undergoing sigmoidoscopy [12, 13]), acute crisis in sickle-cell anemia (31), and physiological stress.
In conclusion, the mononuclear phagocyte affords a unique system for studying clinical and diagnostic aspects of disorders related to receptors, secretory functions, and motility in the monocyte phagocyte system.
The views expressed in this Commentary do not necessarily reflect the views of the journal or of ASM.
ACKNOWLEDGMENTS
I acknowledge undergraduate and graduate students, postdoctoral fellows, faculty, and colleagues with whom I have had the pleasure to work and collaborate in these studies. I also acknowledge my mentors, who nurtured my development as an immunologist.
I acknowledge the National Institutes of Health for major support of these studies. In addition, I acknowledge several other funding agencies that have supported portions of my work during the past three decades, including the Kroc Foundation, National Leukemia Association, March of Dimes, Multiple Sclerosis Foundation, AmFar, and the Pediatric AIDS Foundation. Current support in my laboratory comes from NIH grants RO2 MH 49981, UO1 AI 32921, UO1 HD 32828, NO1 HD3-3162, and UO1 HD DA-32842.
REFERENCES
- 1.Ackerman S K, Douglas S D. Purification of human monocytes on microexudate-coated surfaces. J Immunol. 1978;120:1372–1374. [PubMed] [Google Scholar]
- 2.Collman R, Godfrey B, Cutilli J R, Rhodes A, Hassan N F, Sweet R, Douglas S D, Friedman H, Nathanson N, Gonzalez-Scarano F. Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol. 1990;68:4468–4476. doi: 10.1128/jvi.64.9.4468-4476.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Collman R, Hassan N F, Walker R, Godfrey B, Cutilli J R, Hasting J, Friedman H, Douglas S D, Nathanson N. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1. J Exp Med. 1989;170:1149–1163. doi: 10.1084/jem.170.4.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Davis W C, Huber H, Douglas S D, Fudenberg H H. A defect in circulating mononuclear phagocytes in chronic granulomatous disease in childhood. J Immunol. 1968;101:1093–1095. [PubMed] [Google Scholar]
- 5.Douglas S D, Huber H. Electron microscopic studies of human monocyte and lymphocyte interaction with immunoglobulin- and complement-coated erythrocytes. Exp Cell Res. 1972;760:161–172. doi: 10.1016/0014-4827(72)90194-2. [DOI] [PubMed] [Google Scholar]
- 6.Douglas S D, Schmidt M E, Siltzbach L E. Monocyte receptor activity in normal individuals and patients with sarcoidosis. Immunol Commun. 1972;1:25–38. doi: 10.3109/08820137209022890. [DOI] [PubMed] [Google Scholar]
- 7.Douglas S D, Schmidt M E, Daughaday C C, Siltzbach L E. Kinetics of monocyte receptor activity for immunoproteins in patients with sarcoidosis. Ann N Y Acad Sci. 1976;278:190–200. doi: 10.1111/j.1749-6632.1976.tb47029.x. [DOI] [PubMed] [Google Scholar]
- 8.Douglas S D, Schmidt M E. Mononuclear phagocytes in sarcoidosis. Mt Sinai J Med. 1977;44:761–766. [PubMed] [Google Scholar]
- 9.Douglas S D. Alterations in intramembrane particle distribution during interaction of erythrocyte-bound ligands with immunoprotein receptors. J Immunol. 1978;120:131–157. [PubMed] [Google Scholar]
- 10.Douglas S D. Impact of malnutrition on non-specific defense. In: Isliker H, Schurch B, editors. The impact of parasitic malnutrition on immune defense in parasitic infestation. Vol. 2. Bern, Switzerland: Hans Huber Publishers; 1981. pp. 28–39. [Google Scholar]
- 11.Douglas S D, Ho W-Z. Morphology of monocytes and macrophages. In: Beutler E, Erslev A J, Lichtman M A, Kipps T, editors. Hematology. 5th ed. New York, N.Y: McGraw-Hill; 1995. pp. 861–868. [Google Scholar]
- 12.Fehder W P, Ho W-Z, Campbell D E, Tourtellotte W W, Michaels L A, Cutilli J R, Uvaydova M, Douglas S D. The development and evaluation of a chromatographic procedure for the partial purification of substance P with quantitation by an enzyme immunoassay. Clin Diagn Lab Immunol. 1998;5:303–307. doi: 10.1128/cdli.5.3.303-307.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Fehder W P, Sachs J, Uvaydova M, Douglas S D. Substance P as an immune modulator of anxiety. Neuroimmunomodulation. 1997;4:42–48. doi: 10.1159/000097314. [DOI] [PubMed] [Google Scholar]
- 14.Harris M C, Douglas S D. Nutritional influence on neonatal infections in animal models and man. Ann N Y Acad Sci. 1990;587:246–256. doi: 10.1111/j.1749-6632.1990.tb00152.x. [DOI] [PubMed] [Google Scholar]
- 15.Hassan N F, Campbell D E, Douglas S D. Purification of human monocytes on gelatin coated surfaces. J Immunol Methods. 1986;95:273–276. doi: 10.1016/0022-1759(86)90415-1. [DOI] [PubMed] [Google Scholar]
- 16.Hassan N F, Cutilli J R, Douglas S D. Isolation of highly purified human blood monocytes for in vitro HIV-1 infection studies of monocyte/macrophages. J Immunol Methods. 1990;138:283–285. doi: 10.1016/0022-1759(90)90058-4. [DOI] [PubMed] [Google Scholar]
- 17.Hassan N F, Campbell E E, Rifat S, Douglas S D. Isolation and characterization of human fetal brain derived microglia in in vitro culture. Neuroscience. 1991;41:149–158. doi: 10.1016/0306-4522(91)90205-3. [DOI] [PubMed] [Google Scholar]
- 18.Ho W-Z, Tomassini N, Cherukuri R, Ge S-D, Song L, Lee H-R, Douglas S D. Monokine-mediated increase in human immunodeficiency virus type 1 expression in chronically infected promonocyte- and T-cell-derived lines. Clin Diagn Lab Immunol. 1994;1:517–525. doi: 10.1128/cdli.1.5.517-525.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ho W-Z, Cnaan A, Li Y-H, Zhao H, Lee H-R, Song L, Douglas S D. Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages. AIDS Res Hum Retroviruses. 1996;12:195–198. doi: 10.1089/aid.1996.12.195. [DOI] [PubMed] [Google Scholar]
- 20.Ho W-Z, Kaufman D, Uvaydova M, Douglas S D. Substance P augments interleukin-10 and tumor necrosis factor-α release by human cord blood monocytes and macrophages. J Neuroimmunol. 1996;71:73–80. doi: 10.1016/s0165-5728(96)00132-4. [DOI] [PubMed] [Google Scholar]
- 21.Ho W-Z, Lai J-P, Zhu X-H, Uvaydova M, Douglas S D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol. 1997;159:5654–5660. [PubMed] [Google Scholar]
- 22.Ho W-Z, Lioy J, Song L, Cutilli J R, Polin R A, Douglas S D. Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1. J Virol. 1992;66:573–579. doi: 10.1128/jvi.66.1.573-579.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ho W-Z, Cherukuri R, Douglas S D. The macrophage and HIV-1. In: Zwilling B S, Eisenstein T K, editors. Macrophage-pathogen interactions. New York, N.Y: Marcel Dekker, Inc.; 1994. pp. 569–587. [Google Scholar]
- 24.Huber H, Douglas S D, Fudenberg H H. The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology. 1969;17:7–21. [PMC free article] [PubMed] [Google Scholar]
- 25.Huber H, Douglas S D. Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies. Br J Haematol. 1970;19:19–26. doi: 10.1111/j.1365-2141.1970.tb01597.x. [DOI] [PubMed] [Google Scholar]
- 26.Huber H, Douglas S D, Nusbacher J, Kochwa S, Rosenfield R D. IgG subclass specificity of human monocyte receptor sites. Nature. 1971;229:419–420. doi: 10.1038/229419a0. [DOI] [PubMed] [Google Scholar]
- 27.Kay N E, Douglas S D. Monocyte-erythrocyte interaction in vitro in immune hemolytic anemias. Blood. 1977;50:889–897. [PubMed] [Google Scholar]
- 28.Lai J-P, Douglas S D, Ho W-Z. Human lymphocytes express substance P and its receptor. J Neuroimmunol. 1998;86:80–86. doi: 10.1016/s0165-5728(98)00025-3. [DOI] [PubMed] [Google Scholar]
- 29.Lai J-P, Douglas S D, Rappaport E, Wu J M, Ho W-Z. Identification of a δ isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes. J Neuroimmunol. 1998;91:121–128. doi: 10.1016/s0165-5728(98)00170-2. [DOI] [PubMed] [Google Scholar]
- 30.Lee H-R, Ho W-Z, Douglas S D. Substance P augments tumor necrosis factor release in human monocyte derived macrophages. Clin Diagn Lab Immunol. 1994;1:419–423. doi: 10.1128/cdli.1.4.419-423.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Michaels L A, Ohene-Frempong K, Zhao H, Douglas S D. Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis. Blood. 1998;92:3148–3151. [PubMed] [Google Scholar]
- 32.Schmidt M E, Douglas S D. Disappearance and recovery of human monocyte IgG receptor activity after phagocytosis. J Immunol. 1972;109:914–917. [PubMed] [Google Scholar]
- 33.Schmidt M E, Douglas S D. Monocyte IgG receptor activity, dynamics and modulation—normal individuals and patients with granulomatous disease. J Lab Clin Med. 1977;89:332–340. [PubMed] [Google Scholar]
- 34.Zuckerman S H, Ackerman S K, Douglas S D. Long term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology. 1979;38:401–411. [PMC free article] [PubMed] [Google Scholar]